Desanctis J B, Varesio L, Radzioch D
Institute of Immunology, Central University of Venezuela, Caracas.
Immunology. 1994 Apr;81(4):605-10.
In the present investigation of the effects of prostaglandin E2 (PGE2) on lipoprotein lipase (LPL) gene expression in macrophages, we observed that treatment of macrophages with PGE2 increased the levels of adenosine 3',5'-cyclic monophosphate (cAMP), while the addition of exogenous 5-bromo-cAMP to macrophage cultures resulted in down-regulation of LPL expression. Using indomethacin (INDO), an inhibitor of cyclo-oxygenase and prostaglandins production, we determined that PGE2 acts as a feedback inhibitor of LPL expression. We found that inhibited secretion of LPL protein in lipopolysaccharide (LPS)-treated macrophages could be restored to control levels by the addition of INDO to the medium. In contrast, INDO did not reverse the inhibition of LPL mRNA induced by LPS. Overall, our results have demonstrated that PGE2 is a potent inhibitor of LPL gene expression and indicated that its action may play an important physiological role in the regulation of LPL gene expression during bacterial infections.
在本次关于前列腺素E2(PGE2)对巨噬细胞中脂蛋白脂肪酶(LPL)基因表达影响的研究中,我们观察到用PGE2处理巨噬细胞会增加3',5'-环磷酸腺苷(cAMP)的水平,而向巨噬细胞培养物中添加外源性5-溴-cAMP会导致LPL表达下调。使用吲哚美辛(INDO),一种环氧化酶和前列腺素产生的抑制剂,我们确定PGE2作为LPL表达的反馈抑制剂起作用。我们发现,通过向培养基中添加INDO,脂多糖(LPS)处理的巨噬细胞中LPL蛋白分泌的抑制可恢复到对照水平。相反,INDO不能逆转LPS诱导的LPL mRNA的抑制。总体而言,我们的结果表明PGE2是LPL基因表达的有效抑制剂,并表明其作用可能在细菌感染期间LPL基因表达的调节中发挥重要的生理作用。